ARTIVION INC (AORT) Stock Fundamental Analysis
NYSE:AORT - New York Stock Exchange, Inc. - US2289031005 - Common Stock - Currency: USD
We assign a fundamental rating of 4 out of 10 to AORT. AORT was compared to 191 industry peers in the Health Care Equipment & Supplies industry. AORT has an average financial health and profitability rating. AORT is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year AORT has reported negative net income.
In the past year AORT had a positive cash flow from operations.
AORT had negative earnings in each of the past 5 years.
In multiple years AORT reported negative operating cash flow during the last 5 years.
1.2 Ratios
With a decent Return On Assets value of -1.69%, AORT is doing good in the industry, outperforming 70.68% of the companies in the same industry.
AORT has a better Return On Equity (-4.83%) than 71.73% of its industry peers.
AORT has a Return On Invested Capital of 2.94%. This is in the better half of the industry: AORT outperforms 72.77% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.69% | ||
| ROE | -4.83% | ||
| ROIC | 2.94% |
ROA(3y)-2.68%
ROA(5y)-2.4%
ROE(3y)-7.46%
ROE(5y)-6.47%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Operating Margin of AORT (6.92%) is better than 75.39% of its industry peers.
AORT's Operating Margin has improved in the last couple of years.
The Gross Margin of AORT (64.03%) is better than 64.92% of its industry peers.
In the last couple of years the Gross Margin of AORT has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.92% | ||
| PM (TTM) | N/A | ||
| GM | 64.03% |
OM growth 3Y31.35%
OM growth 5Y5.5%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.05%
GM growth 5Y-0.68%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so AORT is destroying value.
Compared to 1 year ago, AORT has more shares outstanding
Compared to 5 years ago, AORT has more shares outstanding
The debt/assets ratio for AORT is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 1.98 indicates that AORT is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of AORT (1.98) is better than 63.35% of its industry peers.
The Debt to FCF ratio of AORT is 28.76, which is on the high side as it means it would take AORT, 28.76 years of fcf income to pay off all of its debts.
AORT has a better Debt to FCF ratio (28.76) than 69.63% of its industry peers.
AORT has a Debt/Equity ratio of 1.15. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.15, AORT is doing worse than 75.92% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.15 | ||
| Debt/FCF | 28.76 | ||
| Altman-Z | 1.98 |
ROIC/WACC0.32
WACC9.28%
2.3 Liquidity
A Current Ratio of 4.34 indicates that AORT has no problem at all paying its short term obligations.
With a decent Current ratio value of 4.34, AORT is doing good in the industry, outperforming 69.63% of the companies in the same industry.
A Quick Ratio of 3.15 indicates that AORT has no problem at all paying its short term obligations.
AORT has a Quick ratio of 3.15. This is in the better half of the industry: AORT outperforms 67.54% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.34 | ||
| Quick Ratio | 3.15 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 41.89% over the past year.
The Revenue has grown by 9.75% in the past year. This is quite good.
The Revenue has been growing slightly by 7.06% on average over the past years.
EPS 1Y (TTM)41.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-290%
Revenue 1Y (TTM)9.75%
Revenue growth 3Y9.14%
Revenue growth 5Y7.06%
Sales Q2Q%3.88%
3.2 Future
The Earnings Per Share is expected to grow by 49.48% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 9.90% on average over the next years. This is quite good.
EPS Next Y103.95%
EPS Next 2Y71.84%
EPS Next 3Y49.48%
EPS Next 5YN/A
Revenue Next Year8.07%
Revenue Next 2Y9.41%
Revenue Next 3Y9.9%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
AORT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
AORT is valuated quite expensively with a Price/Forward Earnings ratio of 1348.55.
Based on the Price/Forward Earnings ratio, AORT is valued a bit cheaper than the industry average as 66.49% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of AORT to the average of the S&P500 Index (21.32), we can say AORT is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 1348.55 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AORT indicates a somewhat cheap valuation: AORT is cheaper than 71.73% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of AORT indicates a somewhat cheap valuation: AORT is cheaper than 70.16% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 88.6 | ||
| EV/EBITDA | 24.34 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
AORT's earnings are expected to grow with 49.48% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y71.84%
EPS Next 3Y49.48%
5. Dividend
5.1 Amount
AORT does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
22.93
-0.15 (-0.65%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners85.43%
Inst Owner ChangeN/A
Ins Owners5.47%
Ins Owner Change11.72%
Market Cap978.88M
Analysts86.67
Price Target32.98 (43.83%)
Short Float %10.43%
Short Ratio8.74
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-257.33%
Min EPS beat(2)-537.25%
Max EPS beat(2)22.6%
EPS beat(4)2
Avg EPS beat(4)-113.97%
Min EPS beat(4)-537.25%
Max EPS beat(4)168.88%
EPS beat(8)4
Avg EPS beat(8)-108.55%
EPS beat(12)8
Avg EPS beat(12)-41%
EPS beat(16)10
Avg EPS beat(16)-57.97%
Revenue beat(2)0
Avg Revenue beat(2)-3.14%
Min Revenue beat(2)-5.37%
Max Revenue beat(2)-0.91%
Revenue beat(4)1
Avg Revenue beat(4)-1.01%
Min Revenue beat(4)-5.37%
Max Revenue beat(4)3.85%
Revenue beat(8)5
Avg Revenue beat(8)0.8%
Revenue beat(12)7
Avg Revenue beat(12)0.49%
Revenue beat(16)10
Avg Revenue beat(16)7.36%
PT rev (1m)0%
PT rev (3m)-2.51%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-425.91%
EPS NY rev (1m)-89.18%
EPS NY rev (3m)-87.95%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-9.2%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.53%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 1348.55 | ||
| P/S | 2.52 | ||
| P/FCF | 88.6 | ||
| P/OCF | 44.02 | ||
| P/B | 3.54 | ||
| P/tB | N/A | ||
| EV/EBITDA | 24.34 |
EPS(TTM)-0.43
EYN/A
EPS(NY)0.02
Fwd EY0.07%
FCF(TTM)0.26
FCFY1.13%
OCF(TTM)0.52
OCFY2.27%
SpS9.1
BVpS6.47
TBVpS-2.84
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.69% | ||
| ROE | -4.83% | ||
| ROCE | 3.72% | ||
| ROIC | 2.94% | ||
| ROICexc | 3.17% | ||
| ROICexgc | 7.82% | ||
| OM | 6.92% | ||
| PM (TTM) | N/A | ||
| GM | 64.03% | ||
| FCFM | 2.84% |
ROA(3y)-2.68%
ROA(5y)-2.4%
ROE(3y)-7.46%
ROE(5y)-6.47%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y37.89%
ROICexcg growth 5Y4.3%
ROICexc growth 3Y45.07%
ROICexc growth 5Y7.68%
OM growth 3Y31.35%
OM growth 5Y5.5%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.05%
GM growth 5Y-0.68%
F-Score4
Asset Turnover0.49
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.15 | ||
| Debt/FCF | 28.76 | ||
| Debt/EBITDA | 6.21 | ||
| Cap/Depr | 46.22% | ||
| Cap/Sales | 2.88% | ||
| Interest Coverage | 1.1 | ||
| Cash Conversion | 43.53% | ||
| Profit Quality | N/A | ||
| Current Ratio | 4.34 | ||
| Quick Ratio | 3.15 | ||
| Altman-Z | 1.98 |
F-Score4
WACC9.28%
ROIC/WACC0.32
Cap/Depr(3y)42.06%
Cap/Depr(5y)43.23%
Cap/Sales(3y)2.8%
Cap/Sales(5y)3.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)41.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-290%
EPS Next Y103.95%
EPS Next 2Y71.84%
EPS Next 3Y49.48%
EPS Next 5YN/A
Revenue 1Y (TTM)9.75%
Revenue growth 3Y9.14%
Revenue growth 5Y7.06%
Sales Q2Q%3.88%
Revenue Next Year8.07%
Revenue Next 2Y9.41%
Revenue Next 3Y9.9%
Revenue Next 5YN/A
EBIT growth 1Y62.95%
EBIT growth 3Y43.36%
EBIT growth 5Y12.95%
EBIT Next Year105.18%
EBIT Next 3Y41.41%
EBIT Next 5YN/A
FCF growth 1Y-3.05%
FCF growth 3YN/A
FCF growth 5Y7.33%
OCF growth 1Y18.12%
OCF growth 3YN/A
OCF growth 5Y7.04%